Taragarestrant

SI-8086

Taragarestrant, >98% (HPLC)

CAS No. : [2118899-51-5]

Synonyms : D-0502

IUPAC Name : (E)-3-(3,5-Dichloro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic acid

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Taragarestrant is an orally active and selective ERα degrader with strong potency in ER⁺ breast cancer systems. It effectively suppresses ER‑dependent signaling, inhibits proliferation in ER⁺ cell lines, and shows significant antitumor efficacy in xenograft models.

References : Lin W. Y. et al.: Cancer Res., 78(13), 5776, 2018.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.